Navel treatment preparation with effects of phlegm reduction and ventilation

A preparation and umbilical therapy technology, which is applied in the field of phlegm-reducing and ventilating umbilical therapy preparations, can solve problems such as not recommended to be used alone, prone to drug resistance, and obvious side effects, so as to prevent heart and kidney failure, improve human immunity, and improve immunity. effect of ability

Active Publication Date: 2014-08-06
崔建科
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, laboratory data suggest that this type of drug is very prone to drug resistance, and it is not recommended to use it alone
[0004] 2. In the treatment of lung cancer, chemotherapy, radiotherapy, surgery, etc. are often used, with obvious side effects and great harm to the human body

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] A umbilical therapy preparation for reducing phlegm and ventilating air, the umbilical therapy preparation comprises the following raw material components in parts by weight: 28 parts of bellflower, 28 parts of Peucedanum, 12 parts of ephedra, 12 parts of cassia twig, 18 parts of shegan, 18 parts of mountain bean root 22 parts of Scutellaria baicalensis, 22 parts of Forsythia, 22 parts of Cangzhu, 22 parts of Magnolia officinalis, 22 parts of Cyperus cyperi, 18 parts of Galangal, 22 parts of Citrus aurantium, 22 parts of black medicine, 18 parts of Polygonum cuspidatum, 16 parts of rhubarb, 22 parts of calamus 12 parts of polygala, 12 parts of saponins and 18 parts of borneol.

Embodiment 2

[0040] A umbilical therapy preparation for reducing phlegm and ventilating air, the umbilical therapy preparation comprises the following raw material components in parts by weight: 32 parts of bellflower, 28 parts of Peucedanum, 16 parts of ephedra, 16 parts of cassia twig, 16 parts of shegan, 22 parts of mountain bean root 18 parts of Scutellaria baicalensis, 18 parts of forsythia, 18 parts of herb, 18 parts of Magnolia officinalis, 18 parts of Cyperus cyperi, 22 parts of ginger, 18 parts of citrus aurantium, 18 parts of black medicine, 16 parts of knotweed, 18 parts of rhubarb, 18 parts of calamus 16 parts of polygala, 16 parts of saponins and 12 parts of borneol.

Embodiment 3

[0042] A umbilical therapy preparation for reducing phlegm and ventilating air, the umbilical therapy preparation comprises the following raw material components in parts by weight: 30 parts of bellflower, 30 parts of Peucedanum, 15 parts of ephedra, 15 parts of cassia twig, 20 parts of shegan, 20 parts of mountain bean root 20 parts of Scutellaria baicalensis, 20 parts of forsythia, 20 parts of atractylodes, 20 parts of Magnolia officinalis, 20 parts of Cyperus cyperi, 20 parts of ginger, 20 parts of citrus aurantium, 20 parts of black medicine, 15 parts of knotweed, 15 parts of rhubarb, 20 parts of calamus 15 parts of polygala, 15 parts of saponins and 15 parts of borneol.

[0043] Specific case 1

[0044] Xu Haiqing, female, 45 years old, a bank employee. In December 2012, I suffered from influenza, cough, fever, headache, and not thinking about eating. After using the umbilical therapy ointment of the present invention for two times, the cough symptoms were significantly ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a navel treatment preparation with effects of phlegm reduction and ventilation. The navel treatment preparation comprises the following raw components in parts by weight: 25-35 parts of platycodon grandiflorum, 25-35 parts of radix peucedani, 10-20 parts of ephedra, 10-20 parts of cassia twig, 15-25 parts of rhizoma belamcandae, 15-25 parts of subprostrate sophora, 15-25 parts of radix scutellariae, 15-25 parts of fructus forsythiae, 15-25 parts of rhizoma atractylodis, 15-25 parts of magnolia bark, 15-25 parts of rhizoma cyperi, 15-25 parts of galangal, 15-25 parts of frutus aurantii immaturus, 15-25 parts of lindera aggregate, 10-20 parts of giant knotweed, 10-20 parts of rheum officinale, 15-25 pars of calamus, 10-20 parts of polygala tenuifolia, 10-20 parts of gleditsia sinensis and 10-20 of borneol. When being used, the navel treatment preparation is pasted on a navel of a human body, so that medicines can reach each part of the whole body, and therefore, the navel treatment preparation has a remarkable curative effect, remarkable medication safety and a definite curative effect and no toxic or side effects on human bodies and is safe and practical, and convenient to use.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation for external use, in particular to a phlegm-relieving and ventilating navel therapy preparation for treating respiratory diseases. Background technique [0002] At present, in the field of medicine, in the treatment of respiratory diseases, especially severe respiratory diseases such as avian influenza and lung cancer, the treatment methods are limited, and the treatment effect is very unsatisfactory, which is mainly reflected in the following aspects: [0003] 1. Commonly used antiviral drugs for the treatment of avian influenza are Amantadine and Rimantadine. However, laboratory data suggest that this type of drug is extremely prone to drug resistance, and it is not recommended to use it alone. [0004] 2. In the treatment of lung cancer, chemotherapy, radiotherapy, surgery, etc. are often used, with obvious side effects and great harm to the human body. [0005] 3. No matter it is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9062A61P11/10A61P31/16A61P11/00A61P35/00
Inventor 崔建科崔嘉政
Owner 崔建科
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap